Investigation of neuro-inflammatory parameters in a cuprizone induced mouse model of multiple sclerosis

被引:7
|
作者
Avsar, Timucin [1 ]
Celikyapi Erdem, Gokce [2 ]
Terzioglu, Gokhan [3 ]
Tahir Turanli, Eda [2 ,4 ]
机构
[1] Bahcesehir Univ, Sch Med, Med Biol Dept, Istanbul, Turkey
[2] Istanbul Tech Univ, Dr Orhan Ocalgiray Mol Biol & Genet Res Ctr, Istanbul, Turkey
[3] Yeditepe Univ, Inst Sci, Dept Biotechnol, Istanbul, Turkey
[4] Acibadem Univ, Mol Biol & Genet Dept, Istanbul, Turkey
关键词
Cuprizone mouse model; multiple sclerosis; demyelination; cytokines; cellular immune response; oligodendrocyte maturation; DENDRITIC CELLS; T-CELLS; B-CELLS; REMYELINATION; DEMYELINATION; NEUREGULIN-1; SIGNAL;
D O I
10.3906/biy-2104-88
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cuprizone, copper chelator, treatment of mouse is a toxic model of multiple sclerosis (MS) in which oligodendrocyte death, demyelination and remyelination can be observed. Understanding T and B cell subset as well as their cytokines involved in MS pathogenesis still requires further scrutiny to better understand immune component of MS. The study presented here, aimed to evaluate relevant cytokines, lymphocytes, and gene expressions profiles during demyelination and remyelination in the cuprizone mouse model of MS. Eighty male C57BL/6J mice fed with 0.2% cuprizone for eight weeks. Cuprizone has been removed from the diet in the following eight weeks. Cuprizone treated and control mice sacrificed biweekly, and corpus callosum of the brain was investigated by staining. Lymphocyte cells of mice analyzed by flow cytometry with CD3e, CD11b, CD19, CD80, CD86, CD4, CD25 and FOXP3 antibodies. IFNgamma, IL-1alpha, IL-2, IL-5, IL-6, IL-10, IL-17, TNF-alpha cytokines were analyzed in plasma samples. Neuregulin 1 (Nrg1), ciliary neurotrophic factor (Cntf) and C-X-C chemokine receptor type 4 (Cxcr4) gene expressions in corpus callosum sections of the mice brain were quantified. Histochemistry analysis showed that demyelination began at the fourth week of cuprizone administration and total demyelination occurred at the twelfth week in chronic model. Remyelination occurred at the fourth week of following withdrawal of cuprizone from diet. The level of mature and activated T cells, regulatory T cells, T helper cells and mature B cells increased during demyelination and decreased when cuprizone removed from diet. Further, both type 1 and type 2 cytokines together with the proinflammatory cytokines increased. The level of oligodendrocyte maturation and survival genes showed differential gene expression in parallel to that of demyelination and remyelination. In conclusion, for the first-time, involvement of both cellular immune response and antibody response as well as oligodendrocyte maturation and survival factors having role in demyelination and remyelination of cuprizone mouse model of MS have been shown.
引用
收藏
页码:644 / +
页数:13
相关论文
共 50 条
  • [31] PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: A comparison between [11C]CIC and [11C]MeDAS
    Faria, Daniele de Paula
    de Vries, Erik F. J.
    Sijbesma, Jurgen W. A.
    Dierckx, Rudi A. J. O.
    Buchpiguel, Carlos A.
    Copray, Sjef
    NEUROIMAGE, 2014, 87 : 395 - 402
  • [32] Evidence for TGF-β1/Nrf2 Signaling Crosstalk in a Cuprizone Model of Multiple Sclerosis
    Guevara, Coram
    Vicencio, Sinay C.
    Pizarro, Ignacio S.
    Villavicencio-Tejo, Francisca
    Quintanilla, Rodrigo A.
    Astudillo, Pablo
    Ampuero, Estibaliz
    Varas, Rodrigo
    Orellana, Juan A.
    Ortiz, Fernando C.
    ANTIOXIDANTS, 2024, 13 (08)
  • [33] Next Generation Sequencing of Cerebrospinal Fluid B Cell Repertoires in Multiple Sclerosis and Other Neuro-Inflammatory Diseases-A Comprehensive Review
    Ruschil, Christoph
    Kemmerer, Constanze Louisa
    Beller, Lena
    Gabernet, Gisela
    Kowarik, Markus Christian
    DIAGNOSTICS, 2021, 11 (10)
  • [34] Ferulic Acid Ameliorates Cell Injuries, Cognitive and Motor Impairments in Cuprizone-Induced Demyelination Model of Multiple Sclerosis
    Ghobadi, Mojtaba
    Arji, Babak
    Yadegari, Maryam
    Esmailidehaj, Mansour
    Homayouni-Moghadam, Farshad
    Rezvani, Mohammad Ebrahim
    CELL JOURNAL, 2022, 24 (11) : 681 - 688
  • [35] Cognitive disturbances in the cuprizone model of multiple sclerosis
    Kopanitsa, Maksym, V
    Lehtimaki, Kimmo K.
    Forsman, Markku
    Suhonen, Ari
    Koponen, Juho
    Piiponniemi, Tuukka O.
    Karkkainen, Anna-Mari
    Pavlidi, Pavlina
    Shatillo, Artem
    Sweeney, Patrick J.
    Merenlender-Wagner, Avia
    Kaye, Joel
    Orbach, Aric
    Nurmi, Antti
    GENES BRAIN AND BEHAVIOR, 2021, 20 (01)
  • [36] Stem cell therapy for cuprizone model of multiple sclerosis focusing on the effectiveness of different injection methods and cell labeling
    Marzban, Mohsen
    Rustamzadeh, Auob
    Asghari, Aria
    Terme, Yousef
    Amichi, Alireza Gholamnezhad
    Ghanbarzehi, Vahid
    Holaso, Aylar Shahriari
    Hosseini, Fateme
    Shahraki, Mahya
    Sadafi, Paniz
    Hashemzahi, Erfan
    Honardar, Minoo
    Iravankhah, Marziyeh
    Baloochi, Mehdi
    Yarmohammadi, Amin
    Ebrahimi, Pirooz
    ACTA HISTOCHEMICA, 2022, 124 (07)
  • [37] The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis
    Sen, Monokesh K.
    Mahns, David A.
    Coorssen, Jens R.
    Shortland, Peter J.
    GLIA, 2022, 70 (07) : 1215 - 1250
  • [38] Protective effect of crocin on cuprizone-induced model of multiple sclerosis in mice
    Ali Tashakori
    Shahin Hassanpour
    Bita Vazir
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 1713 - 1725
  • [39] Effects of aerobic exercise on demyelination and brain morphology in the cuprizone rat model of multiple sclerosis
    Abbasi, Maryam
    Arghavanfar, Hadis
    Hajinasab, Sepideh
    Nooraei, Aref
    METABOLIC BRAIN DISEASE, 2024, 39 (07) : 1283 - 1290
  • [40] Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model
    Iwasa, K.
    Yamamoto, S.
    Takahashi, M.
    Suzuki, S.
    Yagishita, S.
    Awaji, T.
    Maruyama, K.
    Yoshikawa, K.
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2014, 91 (05): : 175 - 182